Designed to be different

STRAVIX PL Lyopreserved Umbilical Tissue and STRAVIX Cryopreserved Umbilical Tissue are highly versatile, with both wound and surgical applications:

  • Shown to improve the closure rates of challenging wounds as a cover,3 including those with exposed structures or hardware
  • Suitable as a cover for tendon, ligament, bone, nerve repair or soft tissue sites across a wide range of surgical procedures from head to toe, particularly those involving high-risk patients
  • Provide a barrier under incisions

Manufactured using proprietary lyopreservation or cryopreservation processes, blood vessels are removed to prevent an immune response while retaining growth factors and an extracellular matrix rich in hyaluronic acid.1,2


Product Features

Customer Information

Please see each products’ Instructions for Use for important safety information including approved uses.


  • T: 888-674-9551
  • F 443-283-4419

Osiris, STRAVIX PL and STRAVIX Tissue are trademarks of Osiris Therapeutics, Inc., a wholly owned direct subsidiary of Smith+Nephew Consolidated, Inc.
All Trademarks acknowledged.

Recall and Complaints

Customer will provide such support and assistance as S+N may reasonably request in the event of a general or limited voluntary or mandatory recall of the Product(s). Customer shall promptly report any complaint in respect of the Products to

Terms & Conditions and Warranties



1. Dhall S, et al. Bioact Mater. 2018; 4(1): 97-106.

2. Data on file at Osiris Therapeutics, Inc

3. Woo KY. Woundsource (White Paper) 2014.